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INTRODUCTION
Primary Hepatic Leiomyosarcoma (PHL) is a rare malignant tumor arising from
smooth muscle cells of either vascular, biliary, or ligamentous origin. Underlying
etiologic factors are unknown, with few associations described in the literature.
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The median age of diagnosis is 58 years. Diagnosis is often delayed due to
the tumor causing nonspecific symptoms and often remaining asymptomatic
until mass effect is produced. Once PHL presents itself, it is still challenging to
diagnose due to the non-specific nature of symptoms and lack of serological or
2
tumor markers.
This case represents one of thirty cases reported in the literature and is
consistent with the presentation and disease course described by previous case
1
reports in the literature, yet with an interesting difference in the patient’s history.

CASE
A 60-year-old male with extensive travel history to developing countries initially
presented to a medical facility in Micronesia with bilateral lower extremity
edema, dyspnea, fever, and fatigue attributed to an upper respiratory infection.
He ultimately underwent CT of the abdomen and pelvis in Guam, which revealed
a 13.6 x 16.8cm right hepatic lobe mass with obstruction of the IVC. He left
Guam without a definitive diagnosis and presented to our institution two days
later.
On arrival, he complained of non-specific symptoms such as dyspnea, malaise,
weight loss, fever and lower extremity edema. Physical exam was notable for
abdominal distention and palpable organomegaly, bilateral pitting lower extremity
edema to the knee with a desquamating rash on all extremities. Initial vitals:
BP: 115/78 Pulse: 110 Temp: 100.5F Respiration Rate: 20
Due to leukocytosis, fever, and recent travel to developing areas with known
exposures to unclean water, animals, and work as a plumber, the initial leading
diagnoses were largely infectious etiologies. Hepatocellular carcinoma remained
lower on the differential as he had no history of cirrhosis, hepatitis C, or alcohol
abuse.

LAB DATA AND IMAGING

DISCUSSION

A repeat CT scan and an MRI were performed at our institution
(Figure 1 and Figure 2). Due to the suspicion for hepatic abscess,
CT guided drainage was ordered. However, given the solid nature
of the lesion, a CT guided liver biopsy demonstrated nonspecific
fibrotic and infarcted liver parenchyma. As infectious workup and
tumor markers were unrevealing, a repeat biopsy was obtained.
This revealed a poorly differentiated carcinoma without a definitive
primary site. Further imaging studies to assess for additional lesions
and metastatic disease were unrevealing.

PHL is a rare malignant tumor. Most studies are limited to case reports or case series.
In our patient, with an extensive travel history, yet low risk for cirrhosis or hepatocellular
carcinoma, the differential diagnosis initially pointed to infectious disease. Hepatocellular
carcinoma and hyatid disease are often initial diagnoses in other cases eventually
diagnosed with PHL. PHL is especially difficult to diagnose because of the non-specific
symptoms or lab work, including lack of established tumor makers or serological markers.2

Figure 1
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The rarity of the disease makes clinical judgment and standard of care a challenge.
Until recently, surgeries involving the IVC in primary or metastatic liver tumors were
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considered too complex due to high-risk morbidity and mortality. Tumors arising from
the hepatic veins are more prone to develop Budd-Chiari syndrome and have a worse
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prognosis. Yet, surgery offers the only chance for cure. Unfortunately, surgical removal
does not guarantee long-term survival. Alternative therapies, such as radiotherapy and
5
chemotherapy often proved insufficient.
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CONCLUSIONS
Figure 2
Figure 3

The patient underwent open right hepatic lobectomy with resection
of tumor and repair of the IVC with Surgical Oncology and
Cardiothoracic Surgery. The patient tolerated surgery remarkably
well and was subsequently discharged home with plans for potential
adjuvant treatment. Surgical pathology, reviewed by an outside
institution, demonstrated epithelioid elements with regions of smooth
muscle morphology supporting the impression of high-grade PHL
(Figure 3).
The patient underwent a trial of chemotherapy, but ultimately
succumbed to the malignancy within a year.
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•	Primary hepatic leiomyosarcoma is an exceedingly rare liver tumor with a poor
prognosis. The literature on this condition is limited to mostly case reports and series.
•	The characteristically delayed presentation due to nonspecific symptoms and the
challenges with diagnostic and therapeutic modalities all contribute to difficulties with
diagnosis and treatment.
•	Most PHL cases are thought to arise from the wall of major blood vessels. It is likely that
our patient’s tumor originated from a venous structure.
•	Surgical resection is the management of choice with the role of chemotherapy and
radiation not well defined.
•	Although rare, primary hepatic leiomyosarcoma should remain on the differential of
hepatic masses in patients without the classic risk factors for hepatocellular carcinoma.
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